2007
DOI: 10.1016/j.ijcard.2006.03.025
|View full text |Cite
|
Sign up to set email alerts
|

Acute administration of 17β-estradiol reduces endothelin-1 release during pacing-induced ischemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0
1

Year Published

2009
2009
2016
2016

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 39 publications
1
5
0
1
Order By: Relevance
“…The mitogenic contributions of the ET receptor subtypes are different in different types of tumors. Several groups have demonstrated that in epithelial tumors in vitro, the ET-1-induced mitogenic effect is mediated via the ETAR and in nonepithelial tumors in vitro ETBR is involved in this process [17,35,39,41]. The present study showed that even though both ETAR and ETBR are found in LNCaP and PC-3 cells, the mitogenic effect and calcium signaling of ET-1 these cells were mediated predominantly by ETAR.…”
Section: Discussionsupporting
confidence: 48%
See 1 more Smart Citation
“…The mitogenic contributions of the ET receptor subtypes are different in different types of tumors. Several groups have demonstrated that in epithelial tumors in vitro, the ET-1-induced mitogenic effect is mediated via the ETAR and in nonepithelial tumors in vitro ETBR is involved in this process [17,35,39,41]. The present study showed that even though both ETAR and ETBR are found in LNCaP and PC-3 cells, the mitogenic effect and calcium signaling of ET-1 these cells were mediated predominantly by ETAR.…”
Section: Discussionsupporting
confidence: 48%
“…The results of the present study showed that spontaneous proliferation of unstimulated PC-3 cells was inhibited by the ETAR antagonist BQ123, but not by ETBR antagonist BQ788, suggesting that ET-1 is an autocrine growth factor involved in the regulation of prostate cancer cell proliferation. ET-1 and ETAR not only influence cell proliferation directly but also act synergistically with polypeptide growth factors that are relevant to cancer progression, such as EGF and its receptors [38][39][40]. ET-1 is known to exert its action through activation of ETAR and ETBR, both of which are expressed in many tumor cells.…”
Section: Discussionmentioning
confidence: 99%
“…56 Estrogen-associated effects estrogens decrease systemic vascular resistance, restore and improve impaired coronary and peripheral endothelial function in postmenopausal women, [57][58][59] and prevent coronary artery spasm and reduce endothelin release from the coronary circulation in women with and without coronary atherosclerosis. 57,[60][61][62] estrogens are also thought to have an effect on vascular tone and development of CVD in men, since estrogen receptor beta (eRβ) expression increases in male animals following vascular balloon injury, 63,64 and men with mutations that result in defective estrogen synthesis or estrogen receptors have reduced endothelial function and premature development of athero sclerosis. [65][66][67][68] estrogen levels in men are greatly dependent on, and derived from, androgen production: nearly 80% of plasma 17β-estradiol derives from aromatization of testo sterone and andro stenedione ( Figure 2).…”
Section: Direct Cardiovascular Effectsmentioning
confidence: 99%
“…ET-1 has not only been shown to be derived from endothelial cells, but from cardiomyocytes [28] and is thought to be involved in exercise mediated cardiac hypertrophy [29]. Its main function is to act as a potent and long lasting vasoconstrictor that plays a key role in the regulation of vascular tonus [30,31], therefore changes often reflect variations in blood pressure regulation and blood flow.…”
Section: Discussionmentioning
confidence: 99%